The Journal of Allergy and Clinical Immunology

Publication Venue For
- Experience with cultured thymus tissue in 105 children. 2021
- Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach. 2021
- Immune phenotypes in individuals positive for antinuclear antibodies: The impact of race and ethnicity.. 146:1346-1348. 2020
- Ventilation defects on hyperpolarized helium-3 MRI in asthma are predictive of 2-year exacerbation frequency.. 146:831-839.e6. 2020
- Noncanonical autophagy in dermal dendritic cells mediates immunosuppressive effects of UV exposure.. 145:1389-1405. 2020
- Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma.. 145:897-906. 2020
- Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology.. 145:46-69. 2020
- Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.. 143:852-863. 2019
- The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018).. 143:405-407. 2019
- Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series.. 142:1628-1631.e4. 2018
- Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2.. 142:1363-1365.e8. 2018
- Glutathione and arginine levels: Predictors for acetaminophen-associated asthma exacerbation?. 142:308-311.e9. 2018
- Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.. 141:2037-2047.e10. 2018
- Reprograming immunity to food allergens.. 141:1936-1939.e2. 2018
- ADA2 deficiency: Clonal lymphoproliferation in a subset of patients.. 141:1534-1537.e8. 2018
- Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids.. 141:1459-1467.e2. 2018
- Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry.. 141:1028-1035. 2018
- Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications.. 141:918-926.e3. 2018
- Obesity's effect on asthma extends to diagnostic criteria.. 141:1096-1104. 2018
- Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma.. 141:1140-1141.e4. 2018
- Effect of endotoxin and alum adjuvant vaccine on peanut allergy.. 141:791-794.e8. 2018
- Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.. 141:322-328.e10. 2018
- Thymus transplantation for complete DiGeorge syndrome: European experience.. 140:1660-1670.e16. 2017
- Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment.. 140:63-75. 2017
- Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.. 139:1282-1292. 2017
- Individualized therapy for persistent asthma in young children.. 138:1608-1618.e12. 2016
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.. 138:1712-1715. 2016
- Ozone primes alveolar macrophage-derived innate immunity in healthy human subjects.. 138:1213-1215.e1. 2016
- Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.. 138:628-630.e2. 2016
- Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer.. 137:1610-1613.e7. 2016
- Correction notice for TNF-R on mast cells regulate airway responses to Mycoplasma pneumoniae.. 137:336. 2016
- Clinical application of whole-genome sequencing in patients with primary immunodeficiency.. 136:476-9.e6. 2015
- Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.. 135:1519-28.e8. 2015
- Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction.. 135:1063-1065.e5. 2015
- Overweight children report qualitatively distinct asthma symptoms: analysis of validated symptom measures.. 135:886-893.e3. 2015
- Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor.. 135:567-570. 2015
- Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.. 135:283-7.e5. 2015
- Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis.. 134:1084-1092.e1. 2014
- Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.. 134:935-943.e15. 2014
- Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.. 134:155-159. 2014
- Progress in HIV-1 vaccine development.. 134:3-10. 2014
- Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.. 133:1092-1098. 2014
- Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.. 133:1109-1115. 2014
- Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts.. 133:961-966. 2014
- Childhood asthma clusters and response to therapy in clinical trials.. 133:363-369. 2014
- Primary Immune Deficiency Treatment Consortium (PIDTC) report.. 133:335-347. 2014
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.. 133:468-475. 2014
- Elevated IgE and atopy in patients treated for early-onset ADA-SCID.. 132:1444-1446. 2013
- A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders.. 132:713-722.e11. 2013
- High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.. 132:378-386. 2013
- Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison.. 132:476-8.e2. 2013
- Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.. 131:1611-1623. 2013
- Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency.. 131:1604-1610. 2013
- Asthma and the host-microbe interaction.. 131:1449-50.e3. 2013
- B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?. 131:994-1000. 2013
- Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis.. 130:991-994. 2012
- IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies.. 130:829-842. 2012
- Pepsinized cashew proteins are hypoallergenic and immunogenic and provide effective immunotherapy in mice with cashew allergy.. 130:716-723. 2012
- Mast cell TNF receptors regulate responses to Mycoplasma pneumoniae in surfactant protein A (SP-A)-/- mice.. 130:205-14.e2. 2012
- Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.. 129:1562-9.e5. 2012
- Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.. 129:1159-1162. 2012
- The long quest for neonatal screening for severe combined immunodeficiency.. 129:597-604. 2012
- Interpreting low T-cell receptor excision circles in newborns with DiGeorge anomaly: importance of assessing naive T-cell markers.. 128:1375-1376. 2011
- Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.. 128:1266-1276.e11. 2011
- Systemic exposure to fluticasone MDI delivered through antistatic chambers.. 128:1113-5.e1-3. 2011
- Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation.. 128:897-900.e1. 2011
- Role of hyaluronan and hyaluronan-binding proteins in human asthma.. 128:403-411.e3. 2011
- Diacylglycerol kinase ζ deficiency in a non-CD4(+) T-cell compartment leads to increased peanut hypersensitivity.. 128:212-214. 2011
- Eosinophilic esophagitis: updated consensus recommendations for children and adults.. 128:3-20.e6. 2011
- Genome-wide association identifies diverse causes of common variable immunodeficiency.. 127:1360-7.e6. 2011
- Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly.. 127:1351-1355. 2011
- α4β7 Integrin is essential for contact hypersensitivity by regulating migration of T cells to skin.. 126:1267-1276. 2010
- Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation.. 126:814-820.e8. 2010
- Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease.. 125:1125-1127. 2010
- B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review.. 125:790-797. 2010
- Transplantation immunology: solid organ and bone marrow.. 125:S324-S335. 2010
- Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.. 124:1152-60.e12. 2009
- Comèl-Netherton syndrome defined as primary immunodeficiency.. 124:536-543. 2009
- Clinical efficacy and immune regulation with peanut oral immunotherapy.. 124:292-300.97. 2009
- Safety of a peanut oral immunotherapy protocol in children with peanut allergy.. 124:286-291.e6. 2009
- Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model.. 123:231-238.e4. 2009
- Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.. 122:1087-1096. 2008
- A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma.. 122:78-85. 2008
- Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.. 122:166-172.e2. 2008
- Critical issues in mucosal immunity for HIV-1 vaccine development.. 122:3-9. 2008
- Normative values for exhaled breath condensate pH and its relationship to exhaled nitric oxide in healthy African Americans.. 122:101-106. 2008
- Treatment of infants with complete DiGeorge anomaly.. 121:1063. 2008
- Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults.. 121:396-402.e3. 2008
- B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.. 121:13-21. 2008
- Epigallocatechin gallate affects human dendritic cell differentiation and maturation.. 121:209-214. 2008
- Symposium on the Definition and Management of Anaphylaxis: Summary report. 115:584-591. 2005
- Physiologic response to chronic house dust mite exposure in mice is dependent on lot characteristics. 2019

Publication Venue For